Comparison between Anlon Healthcare IPO and BlueStone Jewellery IPO.
Anlon Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while BlueStone Jewellery IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anlon Healthcare IPO is up to ₹121.03 Cr whereas the issue size of the BlueStone Jewellery IPO is up to ₹1,540.65 Cr. The final issue price of Anlon Healthcare IPO is ₹91.00 per share and of BlueStone Jewellery IPO is ₹517.00 per share.
| Anlon Healthcare IPO | BlueStone Jewellery IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹86.00 per share | ₹492.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹517.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹517.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 164 shares | 29 shares |
| Fresh Issue Size | 1,33,00,000 shares | 1,58,60,735 shares |
| Fresh Issue Size (Amount) | up to ₹121.03 Cr | up to ₹820.00 Cr |
| OFS Issue Size | 0 shares | 1,39,39,063 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹720.65 Cr |
| Issue Size Total | 1,33,00,000 shares | 2,97,99,798 shares |
| Issue Size Total (Amount) | up to ₹121.03 Cr | up to ₹1,540.65 Cr |
Anlon Healthcare IPO opens on Aug 26, 2025, while BlueStone Jewellery IPO opens on Aug 11, 2025. The closing date of Anlon Healthcare IPO and BlueStone Jewellery IPO is Aug 29, 2025, and Aug 13, 2025, respectively.
| Anlon Healthcare IPO | BlueStone Jewellery IPO | |
|---|---|---|
| Anchor Bid Date | Aug 25, 2025 | Aug 08, 2025 |
| Issue Open | Aug 26, 2025 | Aug 11, 2025 |
| Issue Close | Aug 29, 2025 | Aug 13, 2025 |
| Basis Of Allotment (Tentative) | Sep 01, 2025 | Aug 14, 2025 |
| Initiation of Refunds (Tentative) | Sep 02, 2025 | Aug 18, 2025 |
| Credit of Share (Tentative) | Sep 02, 2025 | Aug 18, 2025 |
| Listing date (Tentative) | Sep 03, 2025 | Aug 19, 2025 |
| Anchor Lockin End date 1 | Oct 01, 2025 | Sep 12, 2025 |
| Anchor Lockin End date 2 | Nov 30, 2025 | Nov 11, 2025 |
Anlon Healthcare IPO P/E ratio is 17.67, as compared to BlueStone Jewellery IPO P/E ratio of .
| Anlon Healthcare IPO | BlueStone Jewellery IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)BlueStone Jewellery & Lifestyle Ltd.'s revenue increased by 40% and profit after tax (PAT) dropped by 56% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 70.26 | 18.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.68 | 16.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹483.68 Cr. | ₹7823.26 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.45% | -34.53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.93% | -3.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.73 | 0.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.51% | -24.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anlon Healthcare IPO Retail Individual Investors (RII) are offered 13,30,000 shares while in BlueStone Jewellery IPO retail investors are offered 13,30,000 shares. Qualified Institutional Buyers (QIB) are offered 99,75,000 shares in Anlon Healthcare IPO and 89,39,940 shares in BlueStone Jewellery IPO.
| Anlon Healthcare IPO | BlueStone Jewellery IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 1,34,09,910 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 99,75,000 shares | 89,39,940 shares |
| NII | 19,95,000 shares | 44,69,969 shares |
| RII | 13,30,000 shares | 29,79,979 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 1,33,00,000 shares | 2,97,99,798 shares |
Anlon Healthcare IPO subscribed 7.12x in total, whereas BlueStone Jewellery IPO subscribed 2.72x.
| Anlon Healthcare IPO | BlueStone Jewellery IPO | |
|---|---|---|
| QIB (times) | 1.07x | 4.25x |
| NII (times) | 10.61x | 0.57x |
| Big NII (times) | 7.56x | 0.68x |
| Small NII (times) | 16.69x | 0.34x |
| RII (times) | 47.26x | 1.38x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.12x | 2.72x |
